Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
Benjamin WJ, Feng AL, Heft Neal M, Bellile E, Casper KA, Malloy KM, Rosko AJ, Stucken CL, Prince ME, Mierzwa ML, Taylor JMG, Eisbruch A, Spector ME, Wolf GT, Swiecicki PL, Worden FP, Chinn SB.
Benjamin WJ, et al.
Oral Oncol. 2024 Sep;156:106917. doi: 10.1016/j.oraloncology.2024.106917. Epub 2024 Jun 28.
Oral Oncol. 2024.
PMID: 38945011